The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAssura Regulatory News (AGR)

Share Price Information for Assura (AGR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 40.16
Bid: 40.12
Ask: 40.20
Change: -0.34 (-0.84%)
Spread: 0.08 (0.199%)
Open: 40.26
High: 40.98
Low: 40.12
Prev. Close: 40.50
AGR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

3 Oct 2019 07:00

RNS Number : 5770O
Assura PLC
03 October 2019

3 October 2019

Assura plc

Trading Update

For the first half of the year to 30 September 2019

Assura's high-quality portfolio further enhanced; GPI acquisition successfully integrated

Assura plc ("Assura"), the leading primary care property investor and developer, today announces its Trading Update for the first half of the year to 30 September 2019.

Jonathan Murphy, CEO, said:

"Assura has had a very active first six months of the reporting year as we continue to build on our strong progress. The acquisition of GPI, announced in May this year, has been integrated into Assura successfully, and further strengthens our market-leading position, putting us in a better place to provide GPs with the real estate that they need to help alleviate the stresses in the NHS.

"We remain confident in our outlook for the year and look forward to sharing a fuller update at our interim results in November."

Continued improvement to strong portfolio, supported by GPI acquisition

路; Current portfolio of 560 properties.

路; Two developments completed (Darley Dale & South Woodham Ferrers) at a cost of 拢8.4 million and five moved to on site (Canterbury, St Leonards, Hereford, Launceston and Bournville); total of 14 developments on site at the period end with a total development cost of 拢69 million.

路; Nine acquisitions completed in the period at a cost of 拢34.3 million.

路; 14 disposals completed for 拢18 million cash consideration at a small premium to book value at March 2019.

Strong development pipeline offers significant opportunity

路; Immediate development pipeline of 拢72 million.

路; Immediate acquisitions pipeline of 拢65 million, compared with 拢41 million at March 2019.

路; Total immediate pipeline, including on site developments, worth 拢206 million, up from 拢142 million at year end.

Continued rent roll growth

路; 13 lease re-gears agreed on 拢0.9 million of rent, adding weighted average of 8.5 years WAULT to those leases.

路; Annualised rent roll at 拢104.4 million taking account of additions, disposals and rent reviews.

Strong financials provide solid platform as the group continues to grow

路; Issued 拢107 million of privately placed notes announced on 8 August 2019 in two series (10 and 15 years' maturities) with a weighted average interest rate of 2.3%.

路; As at 30 September 2019 gross debt stood at 拢757 million with undrawn facilities of 拢250 million.

Results for the six months ended 30 September 2019 will be announced on 12 November 2019.

ENDS

For further information, please contact:

Assura plc:

Jayne Cottam, CFO

David Purcell, Head of Financial Reporting

Tel: 01925 420 660

Finsbury:

Gordon Simpson

James Thompson

Tel: 0207 251 3801

This announcement contains inside information as defined in Article 7 of the EU Market Abuse Regulation No 596/2014 and has been announced in accordance with the Company's obligations under Article 17 of that Regulation.

Notes to Editors

Assura plc, a constituent of the FTSE 250 and the EPRA* indices, is a UK REIT and long-term investor in and developer of primary care property. The company, headquartered in Warrington, works with GPs, health professionals and the NHS to create outstanding spaces for health services in our communities. At 31 March 2019, Assura's property portfolio was valued at 拢1,979 million.

Further information is available at www.assuraplc.com

*EPRA is a registered trademark of the European Public Real Estate Association.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
END
TSTLLFEEIILFIIA
Date   Source Headline
16th Jul 20124:02 pmRNSChange of Registered Office
13th Jul 201211:16 amRNSDirector/PDMR Shareholding
2nd Jul 20124:12 pmRNSDirector/PDMR Shareholding
26th Jun 20127:00 amRNSPreliminary results for year ended 31 March 2012
30th May 20123:14 pmRNSAppointment of Joint Corporate Broker
23rd May 20122:57 pmRNSDirectorate Change
8th May 20127:00 amRNSDirectorate Change
29th Mar 20127:00 amRNSPre-close statement and Directorate Change
16th Mar 20124:38 pmRNSDirector Declaration
28th Feb 201211:10 amRNSHolding(s) in Company
27th Feb 20129:30 amRNSDirector/PDMR Shareholding
21st Feb 20129:58 amRNSDirector/PDMR Shareholding
13th Feb 20121:33 pmRNSAppointment of Auditors
9th Feb 20127:00 amRNSInterim Management Statement
30th Jan 201212:08 pmRNSDirector/PDMR Shareholding
26th Jan 20127:00 amRNSDirectorate Change
23rd Jan 20123:01 pmRNSDirector/PDMR Shareholding
4th Jan 20123:32 pmRNSDirector / PDMR Shareholding & Total Voting Rights
3rd Jan 20127:00 amRNSDirectorate Change
30th Dec 201112:10 pmRNSHolding(s) in Company
29th Dec 20114:35 pmRNSHolding(s) in Company
28th Dec 20117:00 amRNSHolding(s) in Company
28th Dec 20117:00 amRNSHolding(s) in Company
21st Dec 20113:58 pmRNSResult of Rump Placement
21st Dec 20112:18 pmRNSResult of Rights Issue
16th Dec 201112:32 pmRNSDirector/PDMR Shareholding
9th Dec 20118:16 amRNSDirector/PDMR Shareholding
6th Dec 20119:31 amRNSFurther re Rights Issue
2nd Dec 20111:50 pmRNSPublication of Prospectus
25th Nov 20111:20 pmRNSIssue of Debt
23rd Nov 20117:00 amRNSHalf Yearly Report
23rd Nov 20117:00 amRNSIssue of Equity
13th Oct 20117:00 amRNSHolding(s) in Company
8th Sep 20116:08 pmRNSAGM Statement
1st Sep 20117:00 amRNSAGM - Withdrawal of Resolution
15th Aug 20117:00 amRNSInterim Management Statement
8th Aug 201112:01 pmRNSAnnual Information Update
8th Aug 201110:38 amRNSDirectorate Change
2nd Aug 201112:53 pmRNSDirector/PDMR Shareholding
29th Jul 20114:26 pmRNSAnnual Financial Report
13th Jul 20113:05 pmRNSAdmission of ordinary shares
13th Jul 201111:13 amRNSDisposal of Pharmacy Division
21st Jun 20117:00 amRNSFinal Results
21st Jun 20117:00 amRNSSale of pharmacy division for £39.3m
15th Jun 20119:25 amRNSHolding(s) in Company
17th May 20117:00 amRNSHolding(s) in Company
13th May 20114:03 pmRNSRe Acquisition
5th Apr 20117:00 amRNSTrading Statement
1st Apr 20113:23 pmRNSChange of Address
28th Mar 20113:44 pmRNSAcquisition Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.